» Articles » PMID: 38786057

Mechanisms of Action in FLASH Radiotherapy: A Comprehensive Review of Physicochemical and Biological Processes on Cancerous and Normal Cells

Overview
Journal Cells
Publisher MDPI
Date 2024 May 24
PMID 38786057
Authors
Affiliations
Soon will be listed here.
Abstract

The advent of FLASH radiotherapy (FLASH-RT) has brought forth a paradigm shift in cancer treatment, showcasing remarkable normal cell sparing effects with ultra-high dose rates (>40 Gy/s). This review delves into the multifaceted mechanisms underpinning the efficacy of FLASH effect, examining both physicochemical and biological hypotheses in cell biophysics. The physicochemical process encompasses oxygen depletion, reactive oxygen species, and free radical recombination. In parallel, the biological process explores the FLASH effect on the immune system and on blood vessels in treatment sites such as the brain, lung, gastrointestinal tract, skin, and subcutaneous tissue. This review investigated the selective targeting of cancer cells and the modulation of the tumor microenvironment through FLASH-RT. Examining these mechanisms, we explore the implications and challenges of integrating FLASH-RT into cancer treatment. The potential to spare normal cells, boost the immune response, and modify the tumor vasculature offers new therapeutic strategies. Despite progress in understanding FLASH-RT, this review highlights knowledge gaps, emphasizing the need for further research to optimize its clinical applications. The synthesis of physicochemical and biological insights serves as a comprehensive resource for cell biology, molecular biology, and biophysics researchers and clinicians navigating the evolution of FLASH-RT in cancer therapy.

Citing Articles

Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy.

Chow J Nanomaterials (Basel). 2025; 15(2).

PMID: 39852732 PMC: 11767847. DOI: 10.3390/nano15020117.


Exploring the Metabolic Impact of FLASH Radiotherapy.

Geirnaert F, Kerkhove L, Montay-Gruel P, Gevaert T, Dufait I, De Ridder M Cancers (Basel). 2025; 17(1.

PMID: 39796760 PMC: 11720285. DOI: 10.3390/cancers17010133.


Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly-A Review on Radiotherapy.

Fiorica F, Tebano U, Napoli G, Franceschetto A, Muraro M, Giorgi C Cancers (Basel). 2025; 17(1.

PMID: 39796683 PMC: 11719003. DOI: 10.3390/cancers17010054.


FLASH radiotherapy: mechanisms, nanotherapeutic strategy and future development.

Wang Y, Wang H, Hu J, Chai J, Luan J, Li J Nanoscale Adv. 2025; 7(3):711-721.

PMID: 39781242 PMC: 11705069. DOI: 10.1039/d4na00753k.


Comparative Analysis of Cystamine and Cysteamine as Radioprotectors and Antioxidants: Insights from Monte Carlo Chemical Modeling under High Linear Energy Transfer Radiation and High Dose Rates.

Penabei S, Meesungnoen J, Jay-Gerin J Int J Mol Sci. 2024; 25(19).

PMID: 39408820 PMC: 11477154. DOI: 10.3390/ijms251910490.


References
1.
Adrian G, Konradsson E, Beyer S, Wittrup A, Butterworth K, McMahon S . Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic Conditions. Front Oncol. 2021; 11:686142. PMC: 8358772. DOI: 10.3389/fonc.2021.686142. View

2.
De Ruysscher D, Niedermann G, Burnet N, Siva S, Lee A, Hegi-Johnson F . Radiotherapy toxicity. Nat Rev Dis Primers. 2019; 5(1):13. DOI: 10.1038/s41572-019-0064-5. View

3.
Konradsson E, Arendt M, Bastholm Jensen K, Borresen B, Hansen A, Back S . Establishment and Initial Experience of Clinical FLASH Radiotherapy in Canine Cancer Patients. Front Oncol. 2021; 11:658004. PMC: 8155542. DOI: 10.3389/fonc.2021.658004. View

4.
Zhu H, Xie D, Wang Y, Huang R, Chen X, Yang Y . Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies. Clin Transl Radiat Oncol. 2022; 38:138-146. PMC: 9679438. DOI: 10.1016/j.ctro.2022.11.005. View

5.
Soto L, Casey K, Wang J, Blaney A, Manjappa R, Breitkreutz D . FLASH Irradiation Results in Reduced Severe Skin Toxicity Compared to Conventional-Dose-Rate Irradiation. Radiat Res. 2020; 194(6):618-624. PMC: 7855987. DOI: 10.1667/RADE-20-00090. View